GlycoMimetics Inc <GLYC.OQ> expected to post a loss of 5 cents a share - Earnings Preview

• GlycoMimetics Inc GLYC.OQ GLYC.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025

• ​LSEG's mean analyst estimate for GlycoMimetics Inc is for a loss of 5 cents per share.

• The one available analyst rating on the shares is "buy".

• The average consensus recommendation for the biotechnology & medical research peer group is also "Buy".​

• Wall Street's median 12-month price target for GlycoMimetics Inc is $1.00​, above​ its last closing price of $0.26. ​​​

This summary was machine generated May 5 at 13:26 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)